Sub-second kinetics of the nitric oxide receptor, soluble guanylyl cyclase, in intact cerebellar cells

被引:96
作者
Bellamy, TC [1 ]
Garthwaite, J [1 ]
机构
[1] UCL, Wolfson Inst Biomed Res, London WC1E 6BT, England
关键词
D O I
10.1074/jbc.M006677200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Soluble guanylyl cyclase (sGC) catalyzes cGMP synthesis and serves as a physiological receptor for nitric oxide (NO)). Recent evidence indicates that key properties of sGC within cells differ from those of purified sGC. We have devised a technique for resolving NO-stimulated sGC activity in cells on a sub-second time scale, enabling the first quantitative description of the kinetics of the enzyme within its natural environment. Upon release of NO from a caged derivative, sGC became activated without any lag observable at a 20-ms sampling time. Deactivation of sGC on removal of NO occurred with a rate constant of 3.7 s(-1), which is 25-fold faster than the fastest estimate for purified sGC. Desensitization of sGC occurred with a time constant of 6.9 s at an estimated 70 nM NO and became faster at a higher concentration, indicating that NO accelerates desensitization. The concentration-response curve for NO consequently became increasingly bell-shaped with time, a phenomenon that causes the apparent potency of NO to increase with time. The results indicate that sGC within cells behaves in a highly dynamic fashion, allowing the NO-cGMP pathway to operate within a kinetic framework more resembling that of neurotransmission than the properties of purified sGC suggest.
引用
收藏
页码:4287 / 4292
页数:6
相关论文
共 31 条
[21]   Activation and desensitization properties of native and recombinant kainate receptors [J].
Paternain, AV ;
Rodríguez-Moreno, A ;
Villarroel, A ;
Lerma, J .
NEUROPHARMACOLOGY, 1998, 37 (10-11) :1249-1259
[22]   THE KINETICS OF THE RESPONSE TO GLUTAMATE AND KAINATE IN NEURONS OF THE AVIAN COCHLEAR NUCLEUS [J].
RAMAN, IM ;
TRUSSELL, LO .
NEURON, 1992, 9 (01) :173-186
[23]   Functional properties of a naturally occurring isoform of soluble guanylyl cyclase [J].
Russwurm, M ;
Behrends, S ;
Harteneck, C ;
Koesling, D .
BIOCHEMICAL JOURNAL, 1998, 335 :125-130
[24]   THE USE OF OXYHEMOGLOBIN TO EXPLORE THE EVENTS UNDERLYING INHIBITION OF PLATELET-AGGREGATION INDUCED BY NO OR NO-DONORS [J].
SALVEMINI, D ;
RADZISZEWSKI, W ;
KORBUT, R ;
VANE, J .
BRITISH JOURNAL OF PHARMACOLOGY, 1990, 101 (04) :991-995
[25]   Release of nitric oxide from donors with known half-life: A mathematical model for calculating nitric oxide concentrations in aerobic solutions [J].
Schmidt, K ;
Desch, W ;
Klatt, P ;
Kukovetz, WR ;
Mayer, B .
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1997, 355 (04) :457-462
[26]  
Schrammel A, 1996, MOL PHARMACOL, V50, P1
[27]   Activation of soluble guanylate cyclase by carbon monoxide and nitric oxide: A mechanistic model [J].
Sharma, VS ;
Magde, D .
METHODS-A COMPANION TO METHODS IN ENZYMOLOGY, 1999, 19 (04) :494-505
[28]   SOLUBLE GUANYLATE-CYCLASE FROM BOVINE LUNG - ACTIVATION WITH NITRIC-OXIDE AND CARBON-MONOXIDE AND SPECTRAL CHARACTERIZATION OF THE FERROUS AND FERRIC STATES [J].
STONE, JR ;
MARLETTA, MA .
BIOCHEMISTRY, 1994, 33 (18) :5636-5640
[29]   Spectral and kinetic studies on the activation of soluble guanylate cyclase by nitric oxide [J].
Stone, JR ;
Marletta, MA .
BIOCHEMISTRY, 1996, 35 (04) :1093-1099
[30]   MODELS OF THE DIFFUSIONAL SPREAD OF NITRIC-OXIDE - IMPLICATIONS FOR NEURAL NITRIC-OXIDE SIGNALING AND ITS PHARMACOLOGICAL PROPERTIES [J].
WOOD, J ;
GARTHWAITE, J .
NEUROPHARMACOLOGY, 1994, 33 (11) :1235-1244